A carregar...
Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma
Sorafenib, the unique drug as first-line treatment for advanced hepatocellular carcinoma (HCC), has opened a window of hope after searching for effective agents to combat HCC for decades. However, the overall outcomes are far from satisfactory. One of the explanations is the genetic heterogeneity of...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Co., Limited
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3724962/ https://ncbi.nlm.nih.gov/pubmed/23898367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v5.i7.345 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|